Literature DB >> 32415856

Technical Note: Cardiac synchronized volumetric modulated arc therapy for stereotactic arrhythmia radioablation - Proof of principle.

Justin Poon1, Kirpal Kohli2, Marc W Deyell3, Devin Schellenberg4, Stefan Reinsberg1, Tony Teke5, Steven Thomas6.   

Abstract

PURPOSE: Ventricular tachycardia (VT) is a rapid, abnormal heart rhythm that can lead to sudden cardiac death. Current treatment options include antiarrhythmic drug therapy and catheter ablation, both of which have only modest efficacy and have potential complications. Cardiac radiosurgery has the potential to be a noninvasive and efficient treatment option for VT. Cardiac motion, however, must be accounted for to ensure accurate dose delivery to the target region. Cardiac synchronized volumetric modulated arc therapy (CSVMAT) aims to minimize the dose delivered to normal tissues by synchronizing beam delivery with a cardiac signal, irradiating only during the quiescent intervals of the cardiac cycle (when heart motion is minimal) and adjusting the beam delivery speed in response to heart rate changes.
METHODS: A CSVMAT plan was adapted from a conventional VMAT plan and delivered on a Varian TrueBeam linear accelerator. The original VMAT plan was divided into three interleaved CSVMAT phases, each consisting of alternating beam-on and beam-off segments synchronized to a sample heart rate. Trajectory log files were collected for the original VMAT and CSVMAT deliveries and the dose distributions were measured with Gafchromic EBT-XD film.
RESULTS: Analysis of the trajectory log files showed successful synchronization with the sample cardiac signal. Film analysis comparing the original VMAT and CSVMAT dose distributions returned a gamma passing rate of 99.14% (2%/2 mm tolerance).
CONCLUSIONS: The film results indicated excellent agreement between the dose distributions of the original and cardiac synchronized beam deliveries. This study demonstrates a proof of principle cardiac synchronization strategy for precise radiation treatment plan delivery and adjustment to a variable heart rate. The cardiac synchronized technique may be advantageous in radioablation for VT.
© 2020 American Association of Physicists in Medicine.

Entities:  

Keywords:  cardiac radiosurgery; stereotactic arrhythmia radioablation; ventricular tachycardia

Mesh:

Year:  2020        PMID: 32415856     DOI: 10.1002/mp.14237

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  3 in total

1.  Case Report: Treatment Planning Study to Demonstrate Feasibility of Transthoracic Ultrasound Guidance to Facilitate Ventricular Tachycardia Ablation With Protons.

Authors:  Rosalind Perrin; Patrick Maguire; Adriano Garonna; Georg Weidlich; Shelley Bulling; Marie Fargier-Voiron; Cedric De Marco; Eleonora Rossi; Mario Ciocca; Viviana Vitolo; Alfredo Mirandola
Journal:  Front Cardiovasc Med       Date:  2022-05-04

2.  Stereotactic body radioablation therapy as an immediate and early term antiarrhythmic palliative therapeutic choice in patients with refractory ventricular tachycardia.

Authors:  Dursun Aras; Elif Hande Özcan Çetin; Huseyin Furkan Ozturk; Elif Ozdemir; Meryem Kara; Firdevs Aysenur Ekizler; Ozcan Ozeke; Firat Ozcan; Ahmet Korkmaz; Umit Kervan; Nesrin Turhan; Nazim Coskun; Yilmaz Tezcan; Henry Huang; Tolga Aksu; Serkan Topaloglu
Journal:  J Interv Card Electrophysiol       Date:  2022-08-30       Impact factor: 1.759

3.  Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.

Authors:  Tzu-Hui Pao; Wei-Lun Chang; Nai-Jung Chiang; Jeffrey Shu-Ming Chang; Chia-Ying Lin; Wu-Wei Lai; Yau-Lin Tseng; Yi-Ting Yen; Ta-Jung Chung; Forn-Chia Lin
Journal:  Radiat Oncol       Date:  2020-09-22       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.